October 3 - 6, 2019   Chicago Marriott Downtown Magnificent Mile


Thursday, October 03

8:00 AM Breakfast & Exhibits
9:00 AM Symposium Welcome
William Gradishar, MD
Supportive Oncology and Special Populations
Session Chair: Nora Hansen, MD
9:15 AM Exercise for Breast Cancer Prevention and Treatment
Lee Jones, PhD
9:45 AM Opportunities in a High-Risk Program
Melissa Pilewskie, MD
10:15 AM Managing the Toxicity of Immunotherapy
Jeffrey Sosman, MD
10:45 AM Impact of Local Therapy on Quality of Life
Shoshana Rosenberg, ScD, MPH
11:15 AM Questions & Answers
11:30 AM Lunch
Breast Pathology for the Non-Pathologist
Session Chair: Kalliopi Siziopikou, MD, PhD
1:00 PM Understanding the New HER2 Testing Guidelines
Kalliopi Siziopikou, MD, PhD
1:30 PM Common Diagnostic Problems in Breast Pathology Consultation
Sandra Shin, MD
2:00 PM Special and Rare Histologic Types of Breast Cancer
Jorge Reis-Filho, MD, PhD
2:30 PM Immunopathology of Triple Negative and HER2-Positive Breast Cancer
Ashley Cimino-Mathews, MD
3:00 PM Questions & Answers
3:15 PM Break
Challenging Clinical Cases
Session Chair: William Gradishar, MD
3:45 PM Challenging Clinical Cases Panel
Luis Blanco, Jr., MD; Reem Karmali, MD, MS; John Kim, MD; Jennifer Pincus, MD; Ami Shah, MD; Jonathan Strauss, MD; Carmen Williams, MS, CGC
5:00 PM Welcome Reception

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts

Friday, October 04

7:30 AM Breakfast & Exhibits
Diagnosis and Prevention of Invasive Cancer
Session Chair: Monica Morrow, MD
8:30 AM Genetics Update: Low to Moderate Penetrance Genes: What Do They Mean, What to Do?
Susan Domchek, MD
9:00 AM What’s New in DCIS?
Kimberly Van Zee, MD
9:30 AM RT Decision Making in DCIS
Beryl McCormick, MD
10:00 AM When Can RT be Omitted in Invasive Cancer?
Lawrence Solin, MD
10:30 AM Questions & Answers
10:45 AM Break
De-Escalation of Systemic Therapy to Avoid Chemotherapy in Patients with HER2+ Early Breast Cancer: Is It Possible and In Whom? Break
C. Kent Osborne, MD
12:15 PM Lunch
Management Dilemmas in Neoadjuvant Therapy
Session Chair: V. Craig Jordan, OBE, PhD, DSc
1:30 PM Current Strategies for Inflammatory Breast Cancer
Naoto Ueno, MD, PhD, FACP
2:00 PM Surgical Management of the Breast after NAC
Tari King, MD
2:30 PM Axillary Management after NAC
Andrea Barrio, MD
3:00 PM Break
3:30 PM Optimal Approach to Residual Disease after NAC
William Gradishar, MD
4:00 PM Neoadjuvant Endocrine Therapy
Ingrid Mayer, MD, MSCI
4:30 PM Approach to Radiotherapy after NAC
Thomas Buchholz, MD
5:00 PM Questions & Answers
5:15 PM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts

Saturday, October 05

7:30 AM Breakfast & Exhibits
New Approaches to Poor Prognosis in Breast Cancer
Session Chair: William Gradishar, MD
8:30 AM Immunotherapy in Breast Cancer: The Future is Now
Rita Nanda, MD
9:00 AM New Options for Triple Negative Cancer
Hope Rugo, MD
9:30 AM Surgery in Stage 4 Disease
Seema Khan, MD
10:00 AM Break
10:30 AM Nodal RT: Who Needs It, Who Doesn’t?
Timothy Whelan, MD
11:00 AM Questions & Answers
Breast Cancer, Estrogen and Aging: Implications for Survivors
Patricia Ganz, MD
12:15 PM Lunch
Common Clinical Problems
Session Chair: Seema Khan, MD
1:30 PM Choosing a Genomic Assay for ER+ Breast Cancer
Matthew Goetz, MD
2:00 PM Selective Estrogen Receptor Modulators: Concept to Lives Saved
V. Craig Jordan, OBE, PhD, DSc
2:30 PM Advances in Breast Reconstruction
Hani Sbitany, MD
3:00 PM Questions & Answers
3:15 PM Break
3:30 PM Multidisciplinary Tumor Board with Audience Response Break
Moderator: Monica Morrow, MD; Confirmed Faculty
4:45 PM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts

Sunday, October 06

7:30 AM Breakfast
De-Escalating Therapy
Session Chair: Jonathan Strauss, MD
8:30 AM Conventional vs. Nipple Sparing Mastectomy
Monica Morrow, MD
9:00 AM Endocrine Therapy: Shorter vs. Longer
Virginia Kaklamani, MD
9:30 AM HER2 Directed Therapy: More vs. Less
Eric Winer, MD
10:00 AM APBI vs. Hypofractionation vs. Conventional WBRT
Frank Vicini, MD
10:30 AM Questions & Answers
11:00 AM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts


There will be no breakout sessions in 2019

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts


The Lurie Cancer Center's Lynn Sage Breast Cancer Symposium offers 3.5 days of formal presentations and case discussions.


The Lynn Sage Breast Cancer Symposium is proud of its tradition of attracting a faculty comprised of experts from around the world. Faculty list


Optional, non-CME educational activities are scheduled during times that do not conflict with the Symposium agenda.

Details »

© 2018 Robert H. Lurie Comprehensive Cancer Center